Home » Stocks » ANPC

AnPac Bio-Medical Science Co. Ltd. (ANPC)

Stock Price: $3.21 USD -0.15 (-4.46%)
Updated Oct 30, 2020 4:00 PM EDT - Market closed
After-hours: $3.27 +0.06 (1.87%) Oct 30, 6:25 PM

Stock Price Chart

Key Info

Market Cap 26.77M
Revenue (ttm) 1.55M
Net Income (ttm) -14.44M
Shares Out 8.34M
EPS (ttm) -1.62
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 30, 2020
Last Price $3.21
Previous Close $3.36
Change ($) -0.15
Change (%) -4.46%
Day's Open 3.38
Day's Range 3.18 - 3.46
Day's Volume 18,289
52-Week Range 3.15 - 12.18

More Stats

Market Cap 26.77M
Enterprise Value 31.40M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 8.34M
Float n/a
EPS (basic) n/a
EPS (diluted) -1.62
FCF / Share -0.82
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 8,023
Short Ratio 0.33
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 17.28
PB Ratio 10.91
Revenue 1.55M
Operating Income -12.73M
Net Income -14.44M
Free Cash Flow -7.34M
Net Cash -4.63M
Net Cash / Share -0.56
Gross Margin 44.24%
Operating Margin -821.41%
Profit Margin -931.90%
FCF Margin -473.86%
ROA -105.30%
ROE n/a
ROIC 5,136.30%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Forecasts

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(289.41% upside)
Current: $3.21
Target: 12.50
*Average 12-month USD price target from 2 stock analysts.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Revenue Growth5.8%80.27%-
Gross Profit4.804.581.73
Operating Income-89.08-43.61-40.92
Net Income-101-42.06-39.08
Shares Outstanding8.948.527.94
Earnings Per Share-11.31-4.93-4.92
Operating Cash Flow-48.60-31.15-21.64
Capital Expenditures-2.792.84-2.60
Free Cash Flow-51.39-28.31-24.25
Cash & Equivalents6.1312.8911.41
Total Debt38.5725.9612.50
Net Cash / Debt-32.44-13.07-1.09
Book Value-15.97-22.399.56
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name AnPac Bio-Medical Science Co. Ltd.
Country China
Employees 111
CEO Chang Yu

Stock Information

Ticker Symbol ANPC
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: ANPC
IPO Date January 30, 2020


Anpac Bio-Medical Science Company, a development-stage biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests to corporations and life insurance companies in the People's Republic of China and the United States. It also manufactures cancer differentiation analysis devices; and offers physical checkup package services. The company was founded in 2010 and is headquartered in Lishui, the People's Republic of China.